HU214339B - Eljárás bipiridilek előállítására - Google Patents

Eljárás bipiridilek előállítására Download PDF

Info

Publication number
HU214339B
HU214339B HU9200105A HU9200105A HU214339B HU 214339 B HU214339 B HU 214339B HU 9200105 A HU9200105 A HU 9200105A HU 9200105 A HU9200105 A HU 9200105A HU 214339 B HU214339 B HU 214339B
Authority
HU
Hungary
Prior art keywords
formula
compounds
compound
salts
preparation
Prior art date
Application number
HU9200105A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9200105D0 (en
HUT63832A (en
Inventor
Hans-Georg Capraro
Giorgio Caravatti
Jörg Frei
Jaroslav Stanek
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HU9200105D0 publication Critical patent/HU9200105D0/hu
Publication of HUT63832A publication Critical patent/HUT63832A/hu
Publication of HU214339B publication Critical patent/HU214339B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9200105A 1991-01-14 1992-01-13 Eljárás bipiridilek előállítására HU214339B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8591 1991-01-14

Publications (3)

Publication Number Publication Date
HU9200105D0 HU9200105D0 (en) 1992-04-28
HUT63832A HUT63832A (en) 1993-10-28
HU214339B true HU214339B (hu) 1998-03-02

Family

ID=4178927

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9200105A HU214339B (hu) 1991-01-14 1992-01-13 Eljárás bipiridilek előállítására

Country Status (13)

Country Link
US (1) US5354761A (fr)
EP (1) EP0495749A1 (fr)
JP (1) JPH04312576A (fr)
KR (1) KR920014796A (fr)
AU (1) AU648377B2 (fr)
CA (1) CA2059051A1 (fr)
HU (1) HU214339B (fr)
IE (1) IE920094A1 (fr)
IL (1) IL100603A (fr)
MA (1) MA22385A1 (fr)
MX (1) MX9200120A (fr)
ZA (1) ZA92224B (fr)
ZW (1) ZW692A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69615669T2 (de) * 1995-03-15 2002-07-11 Novartis Ag, Basel Piperidenyl-2-alkyl substituierte lineare polyamine zur senkung intrazellulärer, endogener polyaminkonzentrationen wie z.b. putrescin, spermidin und spermin und ihr einfluss auf die zellvermehrung
AU8704101A (en) * 2000-09-01 2002-03-13 Biogen Inc Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086244A (en) * 1976-12-10 1978-04-25 E. R. Squibb & Sons, Inc. Amidines
US4495934A (en) * 1978-07-25 1985-01-29 Shaw Jr Seth T IUD Arrangement
US4284074A (en) * 1978-07-26 1981-08-18 Shaw Jr Seth T IUD Arrangement
AU538963B2 (en) * 1979-07-09 1984-09-06 Seth Thomas Shaw Jr. Drug for use with an iud
DOP1981004033A (es) * 1980-12-23 1990-12-29 Ciba Geigy Ag Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
US4598073A (en) * 1982-12-06 1986-07-01 Research Corporation Certain polycyclo-palladium-bipyridine complexes having anti-tumor activity
MX16687A (es) * 1988-07-07 1994-01-31 Ciba Geigy Ag Compuestos de biarilo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
HU9200105D0 (en) 1992-04-28
MX9200120A (es) 1992-12-01
MA22385A1 (fr) 1992-10-01
IL100603A (en) 1996-05-14
AU1017692A (en) 1992-07-16
JPH04312576A (ja) 1992-11-04
EP0495749A1 (fr) 1992-07-22
KR920014796A (ko) 1992-08-25
ZA92224B (en) 1992-08-26
HUT63832A (en) 1993-10-28
CA2059051A1 (fr) 1992-07-15
US5354761A (en) 1994-10-11
IL100603A0 (en) 1992-09-06
IE920094A1 (en) 1992-07-15
ZW692A1 (en) 1992-08-08
AU648377B2 (en) 1994-04-21

Similar Documents

Publication Publication Date Title
JP2664241B2 (ja) アリールヒドラゾン
US5064832A (en) Biaryl compounds
EP0751930B1 (fr) Derives amidino utiles comme inhibiteurs de la synthase d'oxyde nitrique
US5859061A (en) Bis-sulfonamides hydroxamic acids as MMP inhibitors
PL170787B1 (en) Method of obtaining an organic salt and n,n'-diacetlocystine
US4438270A (en) α-Halomethyl derivatives of α-amino acids
PL150617B1 (en) The method of production of new hydroxy- and alkoxypirimidine
HUT73169A (en) Aminoacid derivatives as no synthase inhibitors pharmaceutical compns. contg. them and process to prepare the said compds.
US7056894B2 (en) Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
JP2565602B2 (ja) ヒドラゾン
US7053099B1 (en) 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
US5238941A (en) Arylhydrazones and pharmaceutical compositions thereof
HU214339B (hu) Eljárás bipiridilek előállítására
GB2204867A (en) Antifolate pyrimidine compounds
US4560795A (en) α-Halomethyl derivatives of α-amino acids
KR100265307B1 (ko) 하이드라존의 염
EP0808309A1 (fr) Derives de l'imidazole, leur preparation et leur emploi comme inhibiteurs de la s-adenosylmethioninedecarboxylase
JPH10158267A (ja) 新規プリン誘導体およびこれを含む医薬組成物
JPS6239558A (ja) α−シアノアクリル酸アミド誘導体
US3984560A (en) Composition for and method of treating disease caused by protozon
NZ241272A (en) 6,6'-(di)amidine, (di)carboxamido and (di)thiocarboxamido-2,2'-bipyridine derivatives; preparatory processes and pharmaceutical compositions

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVARTIS AG., CH

HMM4 Cancellation of final prot. due to non-payment of fee